INTEGRATED BIOPHARMA INC Quarterly Depreciation in USD from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Integrated Biopharma Inc quarterly/annual Depreciation history and growth rate from Q3 2011 to Q2 2024.
  • Integrated Biopharma Inc Depreciation for the quarter ending June 30, 2024 was $87K, a 3.57% increase year-over-year.
  • Integrated Biopharma Inc Depreciation for the twelve months ending June 30, 2024 was $319K, a 9.12% decline year-over-year.
  • Integrated Biopharma Inc annual Depreciation for 2024 was $319K, a 9.12% decline from 2023.
  • Integrated Biopharma Inc annual Depreciation for 2023 was $351K, a 4.46% increase from 2022.
  • Integrated Biopharma Inc annual Depreciation for 2022 was $336K, a 0.3% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $319K $87K +$3K +3.57% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-20
Q1 2024 $316K $77K -$9K -10.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $325K $78K -$15K -16.1% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $340K $77K -$11K -12.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $351K $84K -$5K -5.62% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-20
Q1 2023 $356K $86K +$3K +3.61% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $353K $93K +$14K +17.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-12
Q3 2022 $339K $88K +$3K +3.53% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $336K $89K +$5K +5.95% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-15
Q1 2022 $331K $83K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $331K $79K -$8K -9.2% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 $339K $85K +$2K +2.41% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $337K $84K +$11K +15.1% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-13
Q1 2021 $326K $83K +$4K +5.06% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $322K $87K +$18K +26.1% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 $304K $83K -$8K -8.79% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $312K $73K -$14K -16.1% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-02
Q1 2020 $326K $79K +$10K +14.5% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $316K $69K +$3K +4.55% Oct 1, 2019 Dec 31, 2019 10-Q 2020-02-12
Q3 2019 $313K $91K +$25K +37.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $288K $87K +$37K +74% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-23
Q1 2019 $251K $69K +$12K +21.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $239K $66K +$9K +15.8% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-12
Q3 2018 $230K $66K -$9K -12% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $239K $50K -$19K -27.5% Apr 1, 2018 Jun 30, 2018 10-K 2019-08-29
Q1 2018 $258K $57K -$14K -19.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $272K $57K -$23K -28.8% Oct 1, 2017 Dec 31, 2017 10-Q 2019-05-15
Q3 2017 $295K $75K +$3K +4.17% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $292K $69K +$3K +4.55% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-12
Q1 2017 $289K $71K +$6K +9.23% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $283K $80K +$24K +42.9% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $259K $72K +$13K +22% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $246K $66K $0 0% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-01
Q1 2016 $246K $65K -$6K -8.45% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $252K $56K -$14K -20% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 $266K $59K -$2K -3.28% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $268K $66K +$8K +13.8% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-02
Q1 2015 $260K $71K +$11K +18.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $249K $70K +$4K +6.06% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-19
Q3 2014 $245K $61K -$8K -11.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $253K $58K -$16K -21.6% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-04
Q1 2014 $269K $60K -$11K -15.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $280K $66K -$5K -7.04% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $285K $69K -$4K -5.48% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $289K $74K -$40K -35.1% Apr 1, 2013 Jun 30, 2013 10-K 2014-09-08
Q1 2013 $329K $71K -$15K -17.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 $344K $71K -$2K -2.74% Oct 1, 2012 Dec 31, 2012 10-Q/A 2014-02-13
Q3 2012 $346K $73K -$13K -15.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $359K $114K Apr 1, 2012 Jun 30, 2012 10-K 2013-09-30
Q1 2012 $86K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $73K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q3 2011 $86K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.